A multi-center clinical study [7] revealed that serum RBP4 levels correlated with the magnitude of insulin resistance in subjects with obesity, impaired glucose tolerance, or type 2 diabetes and in nonobese, nondiabetic subjects with a strong family history of type 2 diabetes. The gene discussed is RBP4; the disease is obesity due to melanocortin 4 receptor deficiency.